COVID-19 vaccines safety surveillance guideline

dc.contributor.author	Ethiopian Food and Drug Authority
dc.date.accessioned	2023-12-25T08:12:35Z
dc.date.available	2023-12-25T08:12:35Z
dc.date.issued	2021-09
dc.identifier.uri	http://repository.iphce.org/xmlui/handle/123456789/2625
dc.description.abstract	On 30 January 2020, World Health Organization (WHO) declared the outbreak due to a novel coronavirus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), also known as COVID-19, as a public health emergency of international concern (PHEIC). It was first reported to WHO on December 31, 2019. By 12 March 2020, due to its rapid global spread, the outbreak was declared a pandemic. As of September 21, 2021, the pandemic has already caused the loss of more than 4.6 million lives. The world is employing different strategies to tackle the pandemic.	en_US
dc.language.iso	English	en_US
dc.subject	Infectious diseases/COVID-19	en_US
dc.title	COVID-19 vaccines safety surveillance guideline	en_US
dc.title.alternative	Integrated Addendum to the Third Edition of The Guideline for Surveillance and Response to Adverse Events Following Immunization, EFDA, Addis Ababa, Ethiopia, Sep 2021.	en_US
dc.type	Guideline	en_US